152 related articles for article (PubMed ID: 34775466)
1. Risk of second primary malignancies in patients with follicular lymphoma: a population-based study in the Netherlands, 1989-2018.
Dinnessen MAW; Visser O; Tonino SH; Posthuma EFM; Blijlevens NMA; Kersten MJ; Lugtenburg PJ; Dinmohamed AG
Blood Cancer J; 2021 Nov; 11(11):179. PubMed ID: 34775466
[No Abstract] [Full Text] [Related]
2. Histological transformation and secondary malignancies in follicular lymphoma.
Vitolo U; Chiappella A
Lancet Haematol; 2018 Nov; 5(11):e496-e497. PubMed ID: 30389030
[No Abstract] [Full Text] [Related]
3. Risk of secondary haematological malignancies in patients with follicular lymphoma: an analysis of 1028 patients treated in the rituximab era.
Prusila REI; Sorigue M; Jauhiainen J; Mercadal S; Postila A; Salmi P; Tanhua T; Tikkanen S; Kakko S; Kuitunen H; Pollari M; Nystrand I; Kuusisto MEL; Vasala K; Jantunen E; Korkeila E; Karihtala P; Sancho JM; Turpeenniemi-Hujanen T; Kuittinen O
Br J Haematol; 2019 Nov; 187(3):364-371. PubMed ID: 31267514
[TBL] [Abstract][Full Text] [Related]
4. Long-term survey of survival time, histological transformation, and secondary malignancies in Japanese patients with advanced-stage follicular lymphoma in the rituximab era: Hokkaido Hematology Study Group.
Hirayama Y; Ishitani K; Ota S; Kurosawa M; Kondo T; Takimoto R; Mori A; Sakai H; Torimoto Y; Yamamoto S; Sato K; Iwasaki H; Kohda K; Ishida T; Kakinoki Y; Fukuhara T; Kato J
Int J Hematol; 2014 Sep; 100(3):281-9. PubMed ID: 25052874
[TBL] [Abstract][Full Text] [Related]
5. Survival outcomes of diffuse large B-cell lymphoma by association with concurrent or antecedent follicular lymphoma and double hit status.
Behdad A; Boddy CS; Fought AJ; Taxter T; Falkiewicz MK; Ayers E; Chen QC; Chen YH; Karmali R; Pro B; Winter JN; Landsburg DJ; Gordon LI; Kaplan JB
Leuk Lymphoma; 2019 Dec; 60(13):3266-3271. PubMed ID: 31225766
[TBL] [Abstract][Full Text] [Related]
6. Sub-clinical dissemination of follicular lymphoma in normal sized lymph nodes may not be detected by radiologic staging: a case of disseminated follicular lymphoma detected in nodal clearance as part of therapy for cutaneous melanoma.
Dickinson M; Wotherspoon A; Cunningham D
Leuk Lymphoma; 2006 Mar; 47(3):553-6. PubMed ID: 16396780
[TBL] [Abstract][Full Text] [Related]
7. Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: a 10-year follow-up analysis of the JCOG0203 trial.
Watanabe T; Tobinai K; Wakabayashi M; Morishima Y; Kobayashi H; Kinoshita T; Suzuki T; Yamaguchi M; Ando K; Ogura M; Taniwaki M; Uike N; Yoshino T; Nawano S; Terauchi T; Hotta T; Nagai H; Tsukasaki K;
Lancet Haematol; 2018 Nov; 5(11):e520-e531. PubMed ID: 30389034
[TBL] [Abstract][Full Text] [Related]
8. Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based Study.
Giri S; Bhatt VR; Verma V; Pathak R; Bociek RG; Vose JM; Armitage JO
Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):569-574. PubMed ID: 28709798
[TBL] [Abstract][Full Text] [Related]
9. 90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years.
Casadei B; Pellegrini C; Pulsoni A; Annechini G; De Renzo A; Stefoni V; Broccoli A; Gandolfi L; Quirini F; Tonialini L; Morigi A; Argnani L; Zinzani PL
Cancer Med; 2016 Jun; 5(6):1093-7. PubMed ID: 26990782
[TBL] [Abstract][Full Text] [Related]
10. Second-line and subsequent therapy and outcomes for follicular lymphoma in the United States: data from the observational National LymphoCare Study.
Link BK; Day BM; Zhou X; Zelenetz AD; Dawson KL; Cerhan JR; Flowers CR; Friedberg JW
Br J Haematol; 2019 Feb; 184(4):660-663. PubMed ID: 29611177
[No Abstract] [Full Text] [Related]
11. Comparison of outcomes after allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma, diffuse large B-cell lymphoma associated with follicular lymphoma, or de novo diffuse large B-cell lymphoma.
Tada K; Kim SW; Asakura Y; Hiramoto N; Yakushijin K; Kurosawa S; Tajima K; Mori S; Heike Y; Tanosaki R; Maeshima AM; Taniguchi H; Furuta K; Kagami Y; Matsuno Y; Tobinai K; Takaue Y; Fukuda T
Am J Hematol; 2012 Aug; 87(8):770-5. PubMed ID: 22641292
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome and mortality trends in early-stage, Grade 1-2 follicular lymphoma treated with radiation therapy.
Guadagnolo BA; Li S; Neuberg D; Ng A; Hua L; Silver B; Stevenson MA; Mauch P
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):928-34. PubMed ID: 16243446
[TBL] [Abstract][Full Text] [Related]
13. Frontline intensive chemotherapy improves outcome in young, high-risk patients with follicular lymphoma: pair-matched analysis from the Czech Lymphoma Study Group Database.
Procházka V; Papajík T; Janíková A; Belada D; Kozák T; Šálek D; Sýkorová A; Móciková H; Campr V; Dlouhá J; Langová K; Fürst T; Trněný M
Leuk Lymphoma; 2017 Mar; 58(3):601-613. PubMed ID: 27666539
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of second malignancies in chronic lymphocytic leukaemia patients as compared with follicular lymphoma patients: a Canadian population-based study.
Beiggi S; Johnston JB; Seftel MD; Pitz MW; Kumar R; Banerji V; Griffith EJ; Gibson SB
Br J Cancer; 2013 Sep; 109(5):1287-90. PubMed ID: 23860531
[TBL] [Abstract][Full Text] [Related]
15. Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial.
Bruna R; Benedetti F; Boccomini C; Patti C; Barbui AM; Pulsoni A; Musso M; Liberati AM; Gini G; Castellino C; Rossini F; Ciceri F; Rota-Scalabrini D; Stelitano C; Di Raimondo F; Tucci A; Devizzi L; Zoli V; Zallio F; Narni F; Dondi A; Parvis G; Semenzato G; Lanza F; Perrone T; Angrilli F; Billio A; Gueli A; Mantoan B; Rambaldi A; Gianni AM; Corradini P; Passera R; Ladetto M; Tarella C
Haematologica; 2019 Nov; 104(11):2241-2248. PubMed ID: 31666344
[TBL] [Abstract][Full Text] [Related]
16. Correlation of the FLIPI score for follicular lymphoma with period of diagnosis and type of treatment.
Arcaini L; Colombo N; Passamonti F; Burcheri S; Orlandi E; Brusamolino E; Della Porta M; Rumi E; Montanari F; Pascutto C; Paulli M; Lazzarino M
Leuk Res; 2006 Mar; 30(3):277-82. PubMed ID: 16112730
[TBL] [Abstract][Full Text] [Related]
17. Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy.
Zucca E; Rondeau S; Vanazzi A; Østenstad B; Mey UJM; Rauch D; Wahlin BE; Hitz F; Hernberg M; Johansson AS; de Nully Brown P; Hagberg H; Ferreri AJM; Lohri A; Novak U; Zander T; Bersvendsen H; Bargetzi M; Mingrone W; Krasniqi F; Dirnhofer S; Hayoz S; Hawle H; Vilei SB; Ghielmini M; Kimby E;
Blood; 2019 Jul; 134(4):353-362. PubMed ID: 31101627
[TBL] [Abstract][Full Text] [Related]
18. High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years.
Gyan E; Foussard C; Bertrand P; Michenet P; Le Gouill S; Berthou C; Maisonneuve H; Delwail V; Gressin R; Quittet P; Vilque JP; Desablens B; Jaubert J; Ramée JF; Arakelyan N; Thyss A; Moluçon-Chabrot C; Delépine R; Milpied N; Colombat P; Deconinck E;
Blood; 2009 Jan; 113(5):995-1001. PubMed ID: 18955565
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of autologous stem-cell transplantation for follicular and transformed follicular lymphoma.
Berglund A; Enblad G; Carlson K; Glimelius B; Hagberg H
Eur J Haematol; 2000 Jul; 65(1):17-22. PubMed ID: 10914935
[TBL] [Abstract][Full Text] [Related]
20. Treatment outcomes and clinical relevance of the Follicular Lymphoma International Prognostic Index in Korean follicular lymphoma patients treated with chemotherapy.
Maeng CH; Ahn SW; Ryu SY; Han S; Ko YH; Ji JH; Kim WS; Kim SJ
Korean J Intern Med; 2016 May; 31(3):560-9. PubMed ID: 26898595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
